Beacon Bridge Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$396K Buy
1,622
+17
+1% +$3.96K 0.13% 81
2025
Q4
$332K Buy
1,605
+127
+9% +$25.1K 0.11% 82
2025
Q3
$274K Buy
1,478
+81
+6% +$13.9K 0.1% 76
2025
Q2
$213K Sell
1,397
-401
-22% -$61.6K 0.08% 82
2025
Q1
$298K Sell
1,798
-12
-0.7% -$1.88K 0.13% 74
2024
Q4
$262K Sell
1,810
-141
-7% -$21.9K 0.11% 78
2024
Q3
$316K Hold
1,951
0.14% 72
2024
Q2
$285K Sell
1,951
-418
-18% -$62.2K 0.13% 78
2024
Q1
$375K Hold
2,369
0.18% 69
2023
Q4
$371K Buy
2,369
+1
+0% +$153 0.19% 66
2023
Q3
$369K Buy
2,368
+25
+1% +$4.13K 0.19% 58
2023
Q2
$388K Buy
2,343
+50
+2% +$8.07K 0.2% 49
2023
Q1
$355K Hold
2,293
0.21% 53
2022
Q4
$405K Buy
+2,293
New +$396K 0.29% 43

Other funds holding JNJ

Beacon Bridge Wealth Partners's JNJ Position: Q1 2026 in Review

Beacon Bridge Wealth Partners increased its Johnson & Johnson (JNJ) stake by 1.1% in Q1 2026, buying an estimated $3.96K and bringing the position to 1,622 shares worth $396K. The position accounts for 0.13% of the portfolio, ranked #81.

Beacon Bridge Wealth Partners first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $405K in Q4 2022. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Beacon Bridge Wealth Partners held 1,622 shares of Johnson & Johnson worth $396K as of Q1 2026.
  • Beacon Bridge Wealth Partners bought 17 Johnson & Johnson shares in Q1 2026, an estimated $3.96K.
  • Johnson & Johnson made up 0.13% of Beacon Bridge Wealth Partners's portfolio in Q1 2026, its #81 holding.
  • Beacon Bridge Wealth Partners first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • Beacon Bridge Wealth Partners's Johnson & Johnson position peaked at $405K in Q4 2022.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Beacon Bridge Wealth Partners's 13F filing for Q1 2026, filed 5 May 2026.